Abstract
AbstractMycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, a disease that claims ~1.5 million lives annually. The current treatment regime is long and expensive, and missed doses contribute to drug resistance. There is much to be understood about the Mtb cell envelope, a complicated barrier that antibiotics need to negotiate to enter the cell. Within this envelope, the plasma membrane is the ultimate obstacle and is proposed to be comprised of over 50% mannosylated phosphatidylinositol lipids (phosphatidyl-myoinositol mannosides, PIMs), whose role in the membrane structure remains elusive. Here we used multiscale molecular dynamics (MD) simulations to understand the structure-function relationship of the PIM lipid family and decipher how they self-organize to drive biophysical properties of the Mycobacterial plasma membrane. To validate the model, we tested known anti-tubercular drugs and replicated previous experimental results. Our results shed new light into the organization of the Mycobacterial plasma membrane and provides a working model of this complex membrane to use for in silico studies. This opens the door for new methods to probe potential antibiotic targets and further understand membrane protein function.Abstract Figure
Publisher
Cold Spring Harbor Laboratory
Reference86 articles.
1. WHO Global Tuberculosis Report 2021; World Health Organization: Geneva, 2021.
2. Treatment of Tuberculosis
3. WHO The End TB Strategy. https://www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategy (accessed 31-1-22).
4. WHO 1.4 million with tuberculosis, lost out on treatment during first year of COVID-19. https://news.un.org/en/story/2021/03/1087962 (accessed 14/4/22).
5. Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane;Scientific Reports,2017
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献